Schippers et al. showed that PGE2 exerts anti-fibrotic activity by modulating cAMP effector Epac-1 production in HSCs, and a COX2 inhibitor, niflumic acid, effectively enhanced mice liver fibrosis induced by CCL4 [37]. Here, CCL4 is linked to Hepatic fibrosis.